Advertisement

Subcutaneous Insulin Pumps

  • Yves ReznikEmail author
  • Emilie Deberles
Chapter

Abstract

Insulin pumps are devices which subcutaneously deliver a continuous amount of rapid-acting insulin analogue as microboluses every few minutes. Such continuous subcutaneous insulin infusion (CSII) delivery pattern insures a reduction of hyperglycemic events and HbA1c after the switch from multiple daily injections in patients with type 1 and type 2 diabetes. Moreover, the coupling of continuous glucose monitoring to pump therapy, named sensor augmented pump, may reduce further HbA1c and the rate of hypoglycemia. Pump use fits especially with flexible insulin therapy, variable amounts of carb consumption, and variable energy expenditure related to physical exercise bouts during the day. A structured education program should be delivered by multidisciplinary teams to insure optimal and safe use of pump devices.

References

  1. 1.
    Pickup JC, Keen H, Parsons JA, Alberti KG. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J. 1978;1:204–7.CrossRefGoogle Scholar
  2. 2.
    Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979;300:573–8.CrossRefGoogle Scholar
  3. 3.
    NHS National Institute for Health and Clinical Excellence: Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus. NICE Technol Appraisal Guidance. London: NICE; 2011, vol 151. p. 1–30.Google Scholar
  4. 4.
    Misso ML, Egberts KJ, Page M, O’Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2010;(1):CD005103.  https://doi.org/10.1002/14651858.CD005103.pub2.
  5. 5.
    Yeh HC, Brown TT, Maruthur N, et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med. 2012;157(5):336–47.CrossRefGoogle Scholar
  6. 6.
    Clements M, Matuleviciene V, Attvall S, et al. Predicting the effectiveness of insulin pump therapy on glycemic control in clinical practice: a retrospective study of patients with type 1 diabetes from 10 outpatient diabetes clinics in Sweden over 5 years. Diabetes Technol Ther. 2015;17(1):21–8.CrossRefGoogle Scholar
  7. 7.
    Bruttomesso D, Crazzolara D, Maran A, et al. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med. 2008;25(3):326–32.CrossRefGoogle Scholar
  8. 8.
    Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008;25:765–74.CrossRefGoogle Scholar
  9. 9.
    Maahs DM, Hermann JM, DuBose SN, et al. Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries. Diabetologia. 2014;57(8):1578–85.CrossRefGoogle Scholar
  10. 10.
    Johnson SR, Cooper MN, Jones TW, et al. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study. Diabetologia. 2013;56(11):2392–400.CrossRefGoogle Scholar
  11. 11.
    Danne T, Schwandt A, Biester T, Heidtmann B, Rami-Merhar B, Haberland H, Müther S, Khodaverdi S, Haak T, Holl RW, DPV Initiative. Long-term study of tubeless insulin pump therapy compared to multiple daily injections in youth with type 1 diabetes: Data from the German/Austrian DPV registry. Pediatr Diabetes. 2018;  https://doi.org/10.1111/pedi.12658.CrossRefGoogle Scholar
  12. 12.
    Maiorino MI, Bellastella G, Casciano O, Cirillo P, Simeon V, Chiodini P, Petrizzo M, Gicchino M, Romano O, Caruso P, Giugliano D, Esposito K. The effects of subcutaneous insulin infusion versus multiple insulin injections on glucose variability in young adults with type 1 diabetes: the 2-year follow-up of the observational METRO study. Diabetes Technol Ther. 2018;20:117–26.CrossRefGoogle Scholar
  13. 13.
    Commissariat PV, Boyle CT, Miller KM, Mantravadi MG, DeSalvo DJ, Tamborlane WV, Van Name MA, Anderson BJ, DiMeglio LA, Laffel LM. Insulin pump use in young children with type 1 diabetes: sociodemographic factors and parent-reported barriers. Diabetes Technol Ther. 2017;19:363–9.CrossRefGoogle Scholar
  14. 14.
    Virk SA, Donaghue KC, Wong TY, Craig ME. Interventions for diabetic retinopathy in type 1 diabetes: systematic review and meta-analysis. Am J Ophthalmol. 2015;160(5):1055–64.CrossRefGoogle Scholar
  15. 15.
    Zabeen B, Craig ME, Virk SA, et al. Insulin pump therapy is associated with lower rates of retinopathy and peripheral nerve abnormality. PLoS One. 2016;11(4):e0153033.CrossRefGoogle Scholar
  16. 16.
    Rosenlund S, Hansen TW, Andersen S, Rossing P. Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow-up study. Diabet Med. 2015;32(11):1445–52.CrossRefGoogle Scholar
  17. 17.
    Rosenlund S, Hansen TW, Rossing P, Andersen S. Effect of sensor-augmented pump treatment versus multiple daily injections on albuminuria: a 1-year randomized study. J Clin Endocrinol Metab. 2015;100(11):4181–8.CrossRefGoogle Scholar
  18. 18.
    Steineck I, Cederholm J, Eliasson B, et al. Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study. BMJ. 2015;350:h3234.  https://doi.org/10.1136/bmj.h3234.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Karges B, Schwandt A, Heidtmann B, Kordonouri O, Binder E, Schierloh U, Boettcher C, Kapellen T, Rosenbauer J, Holl RW. Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. JAMA. 2017;318:1358–66.CrossRefGoogle Scholar
  20. 20.
    Rys PM, Ludwig-Slomczynska AH, Cyganek K, Malecki MT. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies. Eur J Endocrinol. 2018;178:545–63.CrossRefGoogle Scholar
  21. 21.
    Raskin P, Bode BW, Marks JB, et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes. Diabetes Care. 2003;26:2598–603.CrossRefGoogle Scholar
  22. 22.
    Herman WH, Ilag LL, Johnson SL, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care. 2005;28:1568–73.CrossRefGoogle Scholar
  23. 23.
    Berthe E, Lireux B, Coffin C, et al. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous insulin infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure. Horm Metab Res. 2007;39:224–9.CrossRefGoogle Scholar
  24. 24.
    Wainstein J, Metzger M, Boaz M, et al. Insulin pump therapy vs multiple daily injections in obese type 2 diabetic patients. Diabet Med. 2005;22:1037–46.CrossRefGoogle Scholar
  25. 25.
    Reznik Y, Cohen O, Aronson R, Conget I, Castaneda J, Lee SW. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. Lancet. 2014;384:1265–72.CrossRefGoogle Scholar
  26. 26.
    Aronson R, Reznik Y, Conget I, et al. Sustained efficacy of insulin pump therapy, compared with multiple daily injections, in type 2 diabetes: 12-month data from the OpT2mise randomized trial. Diabetes Obes Metab. 2016;18(5):500–7.CrossRefGoogle Scholar
  27. 27.
    Morera J, Joubert M, Morello R, Rod A, Lireux B, Reznik Y. Sustained efficacy of insulin pump therapy in type 2 diabetes: 9-year follow-up in a cohort of 161 patients. Diabetes Care. 2016;39(6):e74–5.CrossRefGoogle Scholar
  28. 28.
    Grunberger G, Bailey TS, Cohen AJ, et al. Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management. Endocr Pract. 2010;16(5):746–62.CrossRefGoogle Scholar
  29. 29.
    Shashaj B, Busetto E, Sulli N. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of pediatric patients using continuous subcutaneous insulin infusion (CSII). Diabet Med. 2008;25:1036–42.CrossRefGoogle Scholar
  30. 30.
    Guenego A, Bouzillé G, Breitel S, et al. Insulin pump failures: has there been an improvement? Update of a prospective observational study. Diabetes Technol Ther. 11 Nov 2016 [Epub ahead of print].Google Scholar
  31. 31.
    Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311–20.CrossRefGoogle Scholar
  32. 32.
    Bergenstal RM, Klonoff DC, Garg SK, et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med. 2013;369(3):224–32.CrossRefGoogle Scholar
  33. 33.
    Cummins E, Royle P, Snaith A, et al. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess. 2010;14(11):iii–v. xi–xvi, 1–181CrossRefGoogle Scholar
  34. 34.
    Pickup JC. Management of diabetes mellitus: is the pump mightier than the pen? Nat Rev Endocrinol. 2012;8(7):425–33.CrossRefGoogle Scholar
  35. 35.
    Pollard DJ, Brennan A, Dixon S, Waugh N, Elliott J, Heller S, Lee E, Campbell M, Basarir H, White D, REPOSE Group. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial. BMJ Open. 2018;8(4):e016766.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Heller S, White D, Lee E, Lawton J, Pollard D, Waugh N, Amiel S, Barnard K, et al. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial. Health Technol Assess. 2017;21(20):1–278.CrossRefGoogle Scholar
  37. 37.
    Roze S, Duteil E, Smith-Palmer J, et al. Cost-effectiveness of continuous subcutaneous insulin infusion in people with type 2 diabetes in the Netherlands. J Med Econ. 2016;19(8):742–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Endocrinology and Diabetes DepartmentCHU Côte de NacreCaen CedexFrance
  2. 2.University of Caen Basse-NormandieMedical SchoolCaenFrance

Personalised recommendations